Background and Objectives: The health system of China in 1970 was an exemplary model to the world but it began deteriorating after the economic reform in 1980. In order to address the deteriorating health system, government of China implemented the ambitious health reform program in 2009, with the aim to provide "safe, effective, convenient and affordable" health service to all people by 2020. In this study we try gain more insight about the health financing system of China prior to health system reform 2009.
INTRODUCTION
In 1970, China depicted a role model of health system with its superior health system performance to the world [1] . Almost universal access to the quality health care was being provided for the entire population; as a consequence, remarkable health performance could be observed [2] . The majority of the people, including both rural and urban, were covered by one of the "health insurance scheme", i.e. government insurance scheme (GIS), labor insurance scheme (LIS) or cooperative medical scheme (CMS) [3] . The shining example of health development started to fade and just became history after the economic reform in 1980 .Central government started to decrease its influential role from health care leading to an increase in the role of private sector. Rapid reduction in the share of the government health expenditure as a proportion of total health expenditure from 40% to 18%, more than half, in between 1980 and 2005 [4] , and privatization of the health institution were some examples of the decrease in government role [5] . Similarly, health insurance coverage was highly affected especially in the rural areas, where about 80% of the workers lacked health insurance in 2003 [6] and an increase in financial burden along with the rise in out-of-pocket payment for health service from 20% to more than 50% between 1980 and 2005 was estimated [4] .
In order to address continually rising health care costs, inadequate resources' allocation to health service, inadequate health insurance coverage, health disparities and health equity, the government of China announced health system reform plan for the next decade in 2009. With the aim to provide "safe, effective, convenient, and affordable" health services to all people by 2020, the government has launched an ambitious three-year 850 billion Yuan RMB action plan, which was implemented in 2009 [7] . The government, in accordance with this three-year plan, aims to include of 90% of population under Primary medical insurance (Urban employees' basic medical insurance scheme (UEBMI), The urban residents' basic medical insurance (URBMI) and New Rural Cooperative Medical Scheme (NRCMS) and to finance the development of health care centers and hospitals in rural town and county, and also community health centers in less developed urban areas. This plan also includes the increase in hospitalized expense imbursement rate under UEBMI, URBMI and NRCMS, up to 75%, 60% and 50% respectively and the increase in average wages [8] [9] [10] . Studies suggest that in the past three decades, along with the problem of health disparities and inequity in resource distribution, China's health system also faces the problems of inadequate heath funding, cost escalation and high personal health expenditure [11] . Health financing always remains the core component of any health system and is fundamental to the ability of health system to maintain and improve human welfare [12] .
In this article we try to explore the health expenditure and health financing of China and gain more insight about how the health care financed in China prior to health system reform; what the trends in health expenditure were, what the major source of health funding were, how revenue was generated, what trends in health financing were and how the population was protected from financial risk. Also, we made a specific comparison of health financing and health outcomes with economically stronger country U.S.A, to understand the performance of health system and the level of health expenditure and health financing in China.
MATERIALS AND METHODS
Data used in this study are secondary type. The fundamental sources of data are online data sets of different national and international agencies depending on the quality and availability of data. Most of the data were derived from online data sets of World Health Organization (WHO), World Bank, Economic Co-operation and Development (OECD), Statistical Yearbook, publicly available reports and documents of related Ministries, and other published sources.
Data for the study of health expenditure and health financing were derived from National Health Account published by WHO. Data for the health insurance were derived from the publicly available published sources like report of national survey published by Ministry of Health and from other related literature.
For demographic and socioeconomic purposes, the online source of World Bank, OECD, and Statistical year book were used. Data from World Health Statistics published by WHO, were used for the health outcome measure. Also other related published reports and documents were used, wherever required. No change in data has been made and because some limitation data were not subjected to verification, we completely relied on the sources for quality of data and methodology of the data collection.
Analysis was done with descriptive approach, focused on the three dimensions of health, namely the financing system: total health expenditure, financing source and financing scheme/agents. We categorized the financing source into public and private and used the available published data for analysis. Financial scheme/agent was also categorized into social health insurance, risk pooling and coverage. Under social health insurance we focused on the available three social health insurance of China (UEBMI, URBMI and NRCMS). In contrast to the financial source, analytical descriptions of financial scheme/ agent were made on the basis of literature review. Simple mathematical calculations were performed to obtain growth rate and percentage of different values, but no significance tests were performed. Since we relied on secondary sources, our analyses have been rearranged and we have tried to compile what is already known about health financing in China. From our analysis, we hope to provide an in-depth knowledge of health financing system of China.
RESULTS
Level of health expenditure: China's total health expenditure (THE) in 2008 was estimated to be 1,317,074 million Yuan RMB, which was about 4.3% of gross domestic product GDP (Table 1) . This share has increased from 3.5% in 1995 but throughout the period it remained below 5% of GDP.
However in real value there has been an increase by more than 6 fold in health expenditure from 212,659 million Yuan (3.5% of GDP,1995) to 1,317,074 million Yuan (4.3% of GDP,2008) . This increasing trend can also be observed in the growth of real per capita health spending. Per capita health expenditure in 1995 was about 21 $, which reached 142$ in 2008 indicating the increase of about 7 fold.
According to figure 1, in 2001, the growth rate of health care expenditure (THE) (8.2%) and growth rate of GDP (8.3%) was similar. Although, growth of both GDP and health care expenditure has increased in almost all the years between 2001 and 2008, health care expenditure attained the faster growth than GDP. As the Health care expenditure showed higher increase in 2002, its growth rate has touched the mark of nearly 14%, which led to larger gap between GDP and the growth rate. Continuous increase in growth rate of GDP and slowing down in health spending rate led to similar growth rate in 2006. Then after, the gap between them has widened because of the faster increase in the growth rate of the health care expenditure and slowing down in the GDP growth rate. In 2008, the GDP growth rate reached 9.6%, the growth rate achieved an increase of 20% compared to the previous year. Similarly, the decline in the population growth rate and incline in growth rate led to the increase in per capita total health spending on health. With the increase in the gross domestic product, health sector also experienced the higher growth rate in terms of total health spending. However the share of THE in terms of GDP did not increase, indicating lower government concern over the health care.
Health source financing in china: Figure 2 explains the contribution of different funding sources towards health expenditure. Low spending in health care was also exacerbated by low public investment and high private share. Public sector and Private sector were two major sources for funding the health care in China. Private health expenditure (PvtHE) constituted the largest source for health financing, bearing about 54% (2008) of the total health expenditure, which is 6.5% higher than the public expenditure on health care.
In 1995, general government had spent about 52% of the total health spending and the difference between the government health spending and private health spending was about 3%. Since 1995, the Government share on health expenditure decreased continuously and reached the lowest level of 36.4 % in 2001, in the contrary, the share of private expenditure had inclined to the peak of 63.6%, leading to a difference of 27% between government and private spending, which affirms the important role played by private sector in health care. From 2001, government health spending increased continuously but the share still remained Public Financing: Public expenditure or government funding allocated to the health sector in 2008 was 615,328 million Yuan RMB, which comprised only about 2% of the GDP and 10% of the total expenses made by the general government. This amount was 5 fold greater than the amount government had allocated in the year 1995. Out of total health expenditure, public expenditure shared about 47% in 2008, 5% lower than 1995 and 10% higher than the 2001. Public financing on health as a proportion of GDP had shown an increase from 1.7% (1995) to 2.03 %( 2008) ( Figure 3 ). This increase did not reflect the higher share of public spending on health care, as the difference between total health expenditure and general government expenditure, as proportion of GDP, had increased over same period. In 1995 the difference was less than 2% which in 2008 increased to more than 2.5%. This was also supported by less government spending on health care compared to total government expense. The share of government expense on health care as a proportion of total government expense was high during 1995-1996 (16%) which later decreased and remained less than 10% of total expense in 2008. Low public spending was further supported by lower per person government expenditure on health and growing difference between per person total health expenditure to per person government spending on health. Generally, Most of the revenue for the public spending comes from tax revenue through budget and contribution to social security fund. In China, social security funds continue to be the largest source for public spending. More than half of the general government revenue for health expenditure arises from the social security financing. Basic medical insurance scheme for urban employees, basic medical insurance for urban residents, new rural cooperative medical scheme and medical assistance program were the financing system responsible for the major contribution on social security fund. In 2007 -2008, about 55% of the general government health expenditure (GGHE) was funded from the social security, which in 1995 was 65% and in 2002-2003 was 54%. Although the percentage contribution of social security towards GGHE decreased, the absolute volume of social security contribution continued to increase. In 2008, out of 615,328 million Yuan RMB allocated by the government for health spending, the social security fund shared about 340,094 million Yuan RMB which in turn was 25% more than the previous year 271,200 million Yuan RMB (2007) and about 5 fold greater than that of 1995. Also local government was more responsible for the public health than the central government, as local and central government sectors accounted for 90% and 10% of health spending funded through general government in 2006 respectively [13] .
Private Financing: As from table 1 and figure 2, private financing was the primary funding mechanism for China health system. High contribution of private expenditure compared to public on total health expenditure highlight the increasing role of private sector on healthcare. Private health care expenditure amounted to 701,746 million yuan in 2008, which was about 54% of total health expenditure and 2.3% of the GDP. Private expenditure on health care has incresaed by 7 fold compared to 103,823 million yuan RMB in 1995. Over the same period its share on total health expenditure had increased from 48.8% in 1995 to achieve the highest level of 64% in 2001 and decreased since then. Although the growth rate of private expenditure seemed to be slower than the public expenditure but its share to total health expenditure was still high. Decrease in growth rate of private financing was also supported by the decrease Essentially, the sources of revenue for private financing were private insurance and out-ofpocket payments, as from Figure 4 .
In China, out-of-pocket expenditure alone accounted for 92% of total private expenditure or about 645,715 million Yuan RMB was paid on health care as out of pocket in 2008, which was around 50% of the total health expenditure. For the last 8 years, household' spending on health has increased with an average growth rate of 11.5 %, observing two trends on its growth. From 2001 to 2006, there was a decrease in the growth rate from 11.4% to 7.3% then started to accelerate to attain the growth rate of nearly 16% in 2008. Also, its share on total GDP had increased from 1.6% in 1995 to 2.13% in 2008. Unlike the growth rate and share to GDP, Out-of pocket payments contribution towards total health expenditure has dropped continuously from 61% in 2001 to 49% in 2008. Although private insurance exists, its coverage is very low and limited and people had to rely on their own source of finance in order to meet the cost of their health care. Only about 50,156 million Yuan RMB was financed from private insurance in 2008, which is about 7% of total private expenditure on health and 3% of total health expenditure. Financing on health care by Private Insurance has been growing slowly and steadily.
For e.g. in 2001 private insurance accounts only 1% of private expenditure on health, and this value has increased by 6% over 8 years.
Financing agents / schemes (HF): With the aim to provide accessible and affordable health service universally, government of China has announced ambitious reform programs to be carried out from 2009 to 2011 [14] . Government, under the three years plan, aims to achieve: Coverage of 90% of population under primary medical insurance, finance for the development of health care centre's and hospitals in rural towns and counties, and community health centre's in less developed urban areas [8] [9] [10] .
Health financing scheme in China was social insurance type, whose policy-making and development was jointly governed by the Ministry of Health and the Ministry of Labor and Social Security, with significant local flexibility [15] .
Social insurance for urban and rural population includes three major schemes (Table 2) :
(1) Urban employees' basic medical insurance scheme (UEBMI) :It was established in 1998 by the Chinese state council and is employment-based medical insurance scheme for urban workers. Participation is mandatory for the employees of both public and private companies [16] . Payroll taxes paid by employer and employees are the source for funding, in which employers and employees share 6% and 2% of the total wages/ salary respectively. This scheme consists of 2 kinds of funds managed by local governments. First one is general medical trust fund, a pooled fund for inpatient stay, which consists of 70% of employer's contribution. Next is individual medical saving account for outpatient service, 70% of employer's contribution goes to this fund. Eligible retirees of bankrupted or closed down enterprises are also covered by this scheme for which subsidies are given by the central government.
(2) The urban residents' basic medical insurance (URBMI): Under this scheme, urban residents who are not covered by UEBMI such as children, student, unemployed urban resident, disabled etc are eligible for the enrollment. It is voluntary type, which was started in 2007, and eligible candidates have to contribute a certain amount for membership. Financing comes from central government with equal contribution from the local government [16] . [17] . In 2010, per person premium was 150 CNY, jointly, central government and local government covered 80% of the premium whereas rest is met by the participants [18] .
Government has improved the subsidy and benefit level of URBMI and NRCMS, increasing the total contribution from government to 120 Yuan per person per annum along with increase in individual premium [14] .
Also, urban and rural poor people who are receiving the minimum living standard allowance are further assisted by the medical financial assistance (MFA) program which began in 2003. Its acts as an important source for the poor people to pay NRCMS premiums and co-payments [18] and financed mutually by central government and local government [19] . Fee-for-service is the most common payment method for physicians, although some provinces use a mix of salary, capitation and free-for-service.
Risk Pooling: National level and provisional level medical insurance fund for the risk pooling does not exist in China [20] . Social insurance system of China features fragmented risk pooling [21] . Individuals are assigned to different financial scheme depending upon their geographical location and employment state, and the responsibility of the authorities for managing insurance fund also differs along with source of financing and enrollment method.
UEBMI and URBMI have the different source of financing one by the employee and employers with mandatory participation, the other by individual and government with voluntary participation. Both are urban based, and consists of medical insurances fund-a pooled insurance fund managed independently by same insurance agent, where the amount contributed for participation is deposited and later used as payment for health service depending upon expenditure. In each administrative region, municipal and county medical insurance bureaus are responsible for managing these funds at local level and for UEBMI provincial medical insurance bureaus area are also responsible for insurance fund for employees and retirees of all government agencies.
On the other hand NRCMS is rural based scheme, where the enrollment is voluntary for family and governments as well as the participants are the source of financing. Risk pooling is at county level and consists of pooled insurance account where all subsidies and revenue collected is deposited. County government and departments of health are responsible for financing, enrollment and managing all payments for the health service coverage in their respective location.
Coverage of social insurance: All together in 2009, the rural and urban basic medical insurance scheme covers more than 1.2 billion people, out of which about 400.61 million people were enrolled in urban basic medical insurance scheme [22, 23] .
In 2008, social insurance scheme gain the coverage of 87% of total population, where NRCMS has the share of 68%, UEBMI 15% and URBMI 4% of total population [14, 18] .
Higher proportion of the rural population, about 90% was covered by the insurance scheme compared to 65% of urban population in 2008 [18] .
NRCMS also experienced the rapid expansion in coverage. Rural resident enrolled to NRCMS have increased from 3% in 2004 to 40.57% in 2006 and in 2009 its covers about 833 million rural resident [17, 18] . Also the numbers of counties have increased to 2451 in 2007, from 310 in 2004 [17] . Rapid increase in the coverage of NRCMS is the major contribution for the growth of total coverage [18] .
DIFFERENTIALS AND SIMILARITIES WITH U.S.A
China has the world's largest population and the highest GDP growth rate, and U.S.A has the world's most expensive health system. In recent years, both U.S.A and China have introduced health system reform. Health insurance coverage has become the highly focused area for both countries' program. Similar problems in two countries in the past years were access to health care, high cost of health service, quality care and disparities. between male to female was higher in China than U.S.A with female having higher prevalence of dying than male before celebrating their 5 th birthday. In contrast, the infant mortality rate and under-5 mortality rate for male in U.S.A was slightly higher than female. Adult mortality rate in both countries were very high, China comparably higher than U.S.A in both male and female, accounting average rate of 113 per 1000 population compared to 107 per 1000 population of U.S.A in 2008. Also the disparity between male and female exists, with female having lower rate than male in both countries. The estimated maternal mortality ratio for China during 2000-2009 was about 34 women per 100,000 births which was more than 2 fold higher than U.S.A. It indicates that the complications during pregnancy and child birth leading to death and disability among women of reproductive age are higher in China compared to that in U.S.A.
DISCUSSION
China, with its vast economic reforms , rapid industrialization and urbanization, on one hand faces challenges of health equity, inadequate health financing, high level of outof-pocket payment , cost escalation , inefficient use of scarce resources and disparities in health provision, whereas, on the other hand, strong economic growth, fiscal position and huge financial reserve have a high potential for substantial increase in the level of health financing, to accelerate protection from financial risks, to reduce burden of health cost and to achieve universal coverage [19] . Study suggests that there will be an increase in health expense as the country becomes wealthier [24] . In high income countries health expenditure growth and government health expenditure growth are faster than the growth of GDP, while outof-pocket payment (OOP) grows at around the same rate as GDP [25] . Similar trend has been observed in our result. With economic reform, rapid industrialization and urbanization, China is quickly marching towards the region of developed country. China's GDP growth rate is the highest in the world averaging 9.6% per year, and growth rate of health expenditure has already overtaken the GDP growth rate. Along with growth in total health expenditure, growth rate of general government expenditure on health has also increased sharply and has surpassed GDP growth rate.
Relative to country's wealth, China channeled low level of resources to health. Its total health expenditure as a proportion of the GDP and low per capita spending on health still remains less than other OECD countries and far below from other strong economic country like U.S.A [26] . During 1980's economic reform, health institutions were redefined as economic bodies rather than welfare entities [5] . Government has the ownership of Majority of health care facilities but for financial survival they rely on revenue generating activities, hence these facilities are termed as "private, for-profit" in terms of behavior [7] . Health didn't become the priority for the central government's agenda; hence government health budget was reduced. Regional disparities were exacerbated by the central government's tax sharing which favor the developed economic region and transfer policies favoring wealthier urban resident [27] . Thus poor localities had to pay from their own source for access to fewer and lower quality services. Central government was less concerned about the health sector and shifted the responsibility towards local government without sufficient funding, which created unfunded mandates in impoverished areas, leading to vast inequalities [28] .
This in turn attributed to high share of private and low share of public funding on total health expenditure for more than a decade. Our study suggests that private health expenditure has dominated the health financing in China contributing more than 50% of THE, and sharing the higher proportion of GDP than that of GGHE. Further, majority of private health expenditure, more than 90% PvtHE or nearly 50% of THE, is dominated by the share of high individual out-of-pocket payment. Together, high outof-pocket payment and decline in the Government's contribution is partly a result of rapidly escalating health care costs and the lack of incentive for cost or quality control in the health delivery system [28] . Some of the contributing factors behind high cost and health inequality were inadequate government funding, and weak supervision and administration of health sector by government [11] . Countries with a high share of out-of-pocket payments are more likely to have a high proportion of households facing catastrophic health expenditure [29] and in China a study between 1998 and 2003 reveals that average rate of catastrophic medical spending increases, and credit entirely goes to rural areas where poorest rural group was the hardest hit [30] .
We also observe that in recent years, trend in China's health financing is just opposite than what they were before. Government is more committed towards health care and health becomes the prioritized agenda for central government. With government focus on universal coverage of health insurance, the share of GGHE on total health expenditure and GDP has increased continuously. However, less than 10% total government expenditure on health in 2008 was even far less than the Abuja declaration (2001), made by the African Union, which endorsed at least 15% of total government expenditure to be allocated to health care [31] .
Private expenditure started to decline and most of it coming from the reduction of out of pocket payment, which once in 2000 shared about 2.7% of GDP have decline to 2.1% of GDP in 2008. Study explains expansion of coverage by rural and urban insurance schemes were reasons behind the reduction of out-of-pocket payment in China [32] . We observe that private health insurance started to flourish in China by increasing their share towards health financing and this may be other additional factor.
With the collapse of the old commune-based rural cooperative in the 1980s, and during the introductory phase of URBMI and NRCMS in mid-to-late 2000s the majority of the Chinese population lacked health insurance coverage [33] . Holding the responsibility to protect citizen from catastrophic health expenditure and universal access to health services, government of China has introduced health system reform in 2009 [7] . Rapid progress has been observed in the health insurance coverage after the health system reform. The three health insurance scheme viz. the new rural cooperative medical scheme (NRCMS), the urban employee-based basic medical insurance scheme (UEBMI) and the urban resident-based basic medical insurance scheme (URBMI) are approaching the universal coverage. Basically Government subsidies and low premium for voluntary participant of NRCMS and URBMI and mandatory participation of UEBMI seem to be the reason behind the rapid coverage. Payroll contribution by employers and employee for UEBMI and subsidies by government for other scheme are expected to relieve the excessive financial burden of health care. Other factor may have the influence on health insurance coverage but we lack research. However, study on rural house hold found that financial protection from NRCMS was limited and health payment induced poverty on rural household after reimbursement did not drop much when compared to that before reimbursement [34] . Although we observe the rapid expansion of health insurance coverage but the coverage in terms of service benefit package and the financial protection provided is very small and limited [19] . In addition, fee for service payment system have increased burden on consumer because this system has created the overuse of health care services and also government administered price setting process which rules out bilateral negotiation between the government and providers has further exacerbated the problems. [35] . As well as the risk pooling is limited to municipality and county level. Hence access of poor people towards health service has not improved much and financial protection against high health cost and expensive health service remains restricted [19] .
Finally the study of specific comparison with U.S.A illuminates the situation and level of health financing and health outcomes of China. In terms of health expenditure and health financing U.S.A outperforms China. China differs highly from the U.S.A in health expenditure and financing because of low level of resources allocated to health care. Huge difference in the share of total health expenditure to GDP and per capita total health spending explains China's low level of health financing and less commitment on the health care. As WHO report claims health expenditure reflects the government as well as household capacity and willingness to spend on health. Viewed as a share of GDP, total national health expenditure reflects the importance of health care in the overall economy [25] . This is also supported by lower share of total government spending on health care. Both systems rely on mix funding source and higher involvement of private entities for financing health care is common in both countries. In U.S.A private insurance is crucial factor for private investment where as in China individuals pay the price for health care. Comparatively high out-of-pocket payment share to private expenditure in China indicates that people are less protected from financial risk while seeking the health care and negligible role of private insurance. Although government spending on health is less, a large number of individuals in China have the social health insurance.
Corresponding to the high expenditure, U.S.A also shows better performance on most of the indicators of health outcome than China. High mortality rate including neonatal, infant, under -5 mortality rate and adult mortality, low life expectancy at birth, low healthy life expectancy at birth and high level of maternal mortality ratio are the reason behind low level of health outcome in China. Study shows health related disparities and inequities are the causes behind the low level of health outcomes in China, which in turn are the results of inadequate government spending, increased out-of-pocket health care cost, and unfair distribution of wealth and health services [36] . Apart from this, infectious diseases were also identified as the main cause for the higher mortality rate and lower life expectancy in China [37] .
CONCLUSION
China is home of nearly 1.3 billion population. To provide quality and effective health service without catastrophic health expenditure for huge population is a strong challenge for the government. Low level of public funding and heavy reliance on out-ofpocket payment were the major problem in the past decades. In addition, people without insurance coverage were unable to pay the heavy cost of health service and those who had were also bound by the limited benefit. Limited role of private insurance and risk pooling limited to local or regional level were also the barriers for the financial protection. Hence the daunting problem of inadequate health financing ruled the last three decade of China health system.
